Coeptis Therapeutics, Inc. Shareholders' Equity
Coeptis Therapeutics, Inc. had Shareholders' Equity of $6.74 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-11-08
- 2022-09-30: Stockholders' Equity Attributable to Parent $6.74M.
- 2022-06-30: Stockholders' Equity Attributable to Parent $2.06M.
- 2022-03-31: Stockholders' Equity Attributable to Parent $2.34M.
- 2021-12-31: Stockholders' Equity Attributable to Parent $2.35M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2022-09-30 | $6.74M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.06M 10-Q · filed 2022-11-08 | |
| 2022-03-31 | $2.34M 10-Q · filed 2022-11-08 | |
| 2021-12-31 | $2.35M 10-Q · filed 2022-11-08 | |
| 2021-09-30 | $572.77K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$2.14M 10-Q · filed 2022-11-08 | -$2.14M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$3.71M 10-Q · filed 2022-11-08 | -$3.71M 10-Q/A · filed 2021-05-18 |
| 2020-12-31 | -$5.14M 10-Q · filed 2022-11-08 | -$44.69K 10-KT · filed 2021-05-11 |
| 2020-11-30 | -$45.16K 10-Q · filed 2021-01-11 | |
| 2020-09-30 | -$2.99M 10-Q · filed 2021-11-15 | |
| 2020-08-31 | -$36.85K 10-Q · filed 2021-01-11 | |
| 2020-06-30 | -$1.92M 10-Q · filed 2021-11-15 | -$1.92M 10-Q · filed 2021-08-16 |
| 2020-05-31 | -$23.10K 10-Q · filed 2021-01-11 | |
| 2020-03-31 | -$1.57M 10-Q · filed 2021-11-15 | -$1.51M 10-Q/A · filed 2021-05-18 |
| 2020-02-29 | -$13.40K 10-KT · filed 2021-05-11 | |
| 2019-12-31 | $919.48K 10-K · filed 2022-03-11 | -$150.00 10-KT · filed 2021-05-11 |
| 2019-08-31 | $0.00 10-Q/A · filed 2020-11-23 | |
| 2019-05-31 | $0.00 10-Q/A · filed 2020-11-23 | |
| 2019-04-29 | $0.00 10-Q/A · filed 2020-11-23 |